The complete of sterile products by Specialty Compounding Inc is recalled by the company itself, quoting major concerns regarding bacterial infection to blood streams. The US Food and Drug Administration (FDA) followed the statement and further publicized it with their own press release to increase the reach of the statement mire widely.
The statement, firstly, is released directly by the manufacturer company’s panel concerning the health objectives of the patients. The statement further cited that the products bought after May 9 should not put into use. The products are suspicious of carrying a contagious disease and should be returned immediate without further delay.
Sterile Products that are being recalled by Specialty Compounding Inc were distributed to patients at almost all US states except the hospitals and pharmacy located in Texas and North Carolina. The press release by FDA also describes the infections developed on patients using this sterile range of products by Specialty Compounding.
Specialty Compounding accounts for making the specialty range of products that are employed for injecting personalized drugs for patients and their contamination may cause immediate health hazards to patients using such products. Compounding pharmacies were checked after fungal infections that killed 63 people in Massachucetts, last year.
Further notifications are also forwarded to every patient by the means of telephonic calls, fax and e-mails. All the users are asked for immediate discontinuation of these products and return them to Specialty Compounding.
In case you are experiencing any problem after use of any concerned product, you can immediately report the reaction to FDA’s MedWatch Adverse Event Reporting program online by the means by fax or mail.
More details are available Specialty Compounding Numbers 512-219-0724, Monday to Friday, between 10:00 a.m.-5:00 p.m.